William R. Henner

Statistics

Publications

Citations

331

H-Index

Active since

2015

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

AbbVie (United States)

William R. Henner is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, cancer pharmacology, and targeted cancer therapy.

Publications per year

2015–2024

Publications

Targeting Notch Signaling with a Notch2/Notch3 Antagonist (Tarextumab) Inhibits Tumor Growth and Decreases Tumor-Initiating Cell Frequency

Wan-Ching Yen, Marcus Fischer, Fumiko Axelrod et al. · Clinical Cancer Research · 2015 · 241 citations

Medicine, Oncology, Pharmacology +14

Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumors

Jason J. Luke, Fabrice Barlési, Ki Y. Chung et al. · Journal for ImmunoTherapy of Cancer · 2021 · 60 citations · Full text

Life Sciences, Immunology, Oncology +17

First-in-human study of ABBV-706, a seizure-related homolog protein 6 (SEZ6)–targeting antibody-drug conjugate (ADC), in patients (pts) with advanced solid tumors.

Sreenivasa R Chandana, Noura J. Choudhury, Afshin Dowlati et al. · Journal of Clinical Oncology · 2024 · 30 citations

Medicine, Oncology, Pharmacology +17

1–3 of 3